Making Lung Cancer Clinical Trials More Inclusive: Recommendations for Expanding Eligibility Criteria

Affiliations

¹ Rush Medical Center, Chicago, Illinois. Electronic address: philip_bonomi@rush.edu.
² U.S. Food and Drug Administration, Silver Spring, Maryland.
³ LUNGevity Foundation, Bethesda, Maryland.
⁴ University of Ottawa, Ottawa, Ontario, Canada.
⁵ WSCollaborative, McLean, Virginia.
⁶ Bristol-Myers Squibb, Princeton, New Jersey.
⁷ Friends of Cancer Research, Washington, DC.
⁸ University of Pennsylvania, Philadelphia, Pennsylvania.
⁹ Eli Lilly, Indianapolis, Indiana.
¹⁰ Genentech, San Francisco, California.

Free article

Philip Bonomi et al. J Thorac Oncol. 2018 Jun.

Free article

. 2018 Jun;13(6):748-751.

doi: 10.1016/j.jtho.2018.02.013.

¹ Rush Medical Center, Chicago, Illinois. Electronic address: philip_bonomi@rush.edu.
² U.S. Food and Drug Administration, Silver Spring, Maryland.
³ LUNGevity Foundation, Bethesda, Maryland.
⁴ University of Ottawa, Ottawa, Ontario, Canada.
⁵ WSCollaborative, McLean, Virginia.
⁶ Bristol-Myers Squibb, Princeton, New Jersey.
⁷ Friends of Cancer Research, Washington, DC.
⁸ University of Pennsylvania, Philadelphia, Pennsylvania.
⁹ Eli Lilly, Indianapolis, Indiana.
¹⁰ Genentech, San Francisco, California.

No abstract available

MeSH terms